Lipidomics studies on macrophages - bone marrow-derived macrophages treated with Kdo2-Lipid A and ATP
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
---|---|---|---|---|---|---|
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 0.3 | MSG090924914 | 0.044 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 0.5 | MSG090924918 | 0.02 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 1.0 | MSG090924922 | 0.007 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 2.0 | MSG090924926 | 0.015 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 4.0 | MSG090924930 | 0.022 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 8.0 | MSG090924934 | 0.054 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 20.0 | MSG090924938 | 0.109 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 0.3 | MSG090924912 | 0.032 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 0.5 | MSG090924916 | 0.009 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 1.0 | MSG090924920 | 0.028 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 2.0 | MSG090924924 | 0.021 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 4.0 | MSG090924928 | 0.018 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 8.0 | MSG090924932 | 0.013 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 20.0 | MSG090924936 | 0.078 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 0.0 | MSG090924910 | 0.026 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 0.3 | MSG090924911 | 0.023 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 0.5 | MSG090924915 | 0.034 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 1.0 | MSG090924919 | 0.033 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 2.0 | MSG090924923 | 0.01 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 4.0 | MSG090924927 | 0.012 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 8.0 | MSG090924931 | 0.023 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 20.0 | MSG090924935 | 0.047 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 0.3 | MSG090924913 | 0.027 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 0.5 | MSG090924917 | 0.009 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 1.0 | MSG090924921 | 0.01 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 2.0 | MSG090924925 | 0.032 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 4.0 | MSG090924929 | 0.014 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 8.0 | MSG090924933 | 0.018 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 20.0 | MSG090924937 | 0.043 | pmol/ug DNA |